Targeting cancer stem cells with phytochemicals

Brian T Kawasaki1, Elaine M Hurt, Tashan Mistree

  • 1Cancer Stem Cell Section, Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702, USA.

Molecular Interventions
|October 3, 2008
PubMed

Insights

Cancer stem cells (SCs) drive tumor growth and relapse. Phytochemicals from plants show promise in targeting these cancer stem cells for improved cancer treatment and prevention.

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Cancer remains a leading cause of death, with limited long-term survival despite advances in detection and therapy.
  • A small population of cancer stem cells (SCs) is implicated in tumor initiation, progression, metastasis, and relapse.
  • Cancer SCs possess unique characteristics, including drug-effluxing capabilities, specific stem cell pathways, anti-apoptotic mechanisms, and differentiation potential, making them therapeutic targets.

Purpose of the Study:

  • To review the evidence supporting the cancer stem cell (CSC) hypothesis.
  • To explore the potential of phytochemicals as a therapeutic strategy against cancer SCs.
  • To discuss the mechanisms by which phytochemicals may target cancer SCs.

Main Methods:

  • Literature review of studies on cancer stem cells.
  • Analysis of research on phytochemicals and their anti-cancer properties.
  • Synthesis of evidence linking phytochemical mechanisms to cancer SC vulnerabilities.

Main Results:

  • The cancer stem cell hypothesis is supported by increasing evidence.
  • Phytochemicals exhibit anti-cancer properties and can target key cancer SC pathways.
  • Potential mechanisms include targeting drug efflux, stem cell signaling, apoptosis, and inducing differentiation.

Conclusions:

  • Cancer stem cells are a critical target for novel cancer therapies.
  • Phytochemicals represent a promising avenue for developing new anti-cancer treatments and preventive strategies.
  • Further research into phytochemicals could lead to more effective cancer interventions targeting cancer stem cells.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...